We didn’t wait for the next advance against cancer. We created it.
Learn why our CSO, Nick Keen, is #NotWaiting.
We didn’t wait for the next advance against cancer. We created it.
Learn why our research teams are #NotWaiting.
We didn’t wait for the next advance against cancer. We created it.
Learn why our U.K. team is #NotWaiting.
View all news

News

14 November, 2018
Bicycle Therapeutics Named Best New Drug Developer at 2018 World ADC Awards

Social Media

@Bicycle_tx Nov 15
Today, Liu gave her oral presentation at #PEGSEurope. So great to be in Lisbon this week at the 10th annual summit. http://t4nmLcZisL

Our Programs

We are focused on developing three categories of Bicycles against our oncology targets:

Bicycle Toxin ConjugatesBicycle Targeted Innate Immune ActivatorsBicycle T-Cell Modulators

Our Technology

Learn about our revolutionary Bicycle technology

Beyond Oncology

Bicycle programs outside of cancer